HEP-1: A Breakthrough Peptide for Anti-HIV and Enhanced Vaccination

Discover the potential of Human ezrin peptide (324-337) in fighting viral infections and boosting immune responses.

Get a Quote & Sample

Key Advantages

Potent Antiviral Properties

The demonstrated anti-HIV activity of HEP-1 makes it a promising candidate for developing novel antiviral treatments, offering a new avenue for combating viral pathogens.

Enhanced Immunogenicity

HEP-1 is shown to significantly improve antibody titers post-hepatitis B vaccination, highlighting its value as an adjuvant or enhancer in vaccine development strategies.

Research Versatility

This peptide is crucial for various research applications, including antibody development, functional studies on protein interactions, and investigating its link to diseases associated with ezrin expression.

Key Applications

Antiviral Research

Explore the use of HEP-1 in developing new strategies against viral infections, building on its known anti-HIV activity and potential for immune enhancement.

Vaccine Development

Investigate HEP-1's capacity to boost immune responses, as evidenced by enhanced antibody titers in hepatitis B vaccination, offering a pathway to more effective vaccines.

Immunology Studies

Utilize HEP-1 to understand complex immune system mechanisms, particularly how peptides can modulate immune responses and potentially treat inflammatory conditions.

Biomedical Research Tool

As a high-purity research chemical, HEP-1 serves as an essential tool for scientists exploring ezrin's role in cell signaling, cancer biology, and various diseases.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).